1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Kronox Lab Sciences Limited

Kronox Lab Sciences Limited

188.01
INR
-9.13
(-4.63%)
7.77EPS
19.30P/E
5.56BMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
16.83
22.17
25.76
24.22
27
27.28
28.64
Basic EPS, GAAP
2.62
3.67
4.48
5.75
6.86
7.45
7.77
Free Cash Flow per Basic Share
2.6
1.41
3.03
1.39
7.44
5.55
- -
Dividend per Share
- -
- -
- -
- -
0.5
0.5
- -
Book Value per Share
7.23
10.88
12.04
17.87
24.28
31.3
- -
Tangible Book Value per Share
7.23
10.88
12.04
17.87
24.28
31.3
- -
Basic Weighted Avg Shares
37
37
37
37
37
37
37
Sales/Revenue/Turnover
625
822
956
899
1,002
1,012
1,053
Operating Margin (%)
20.8
21.78
21.45
30.46
32.13
32.35
31.42
Depreciation Expense
20
20
15
13
14
20
21
Net Income, GAAP
97
136
166
214
255
277
286
Effective Tax Rate (%)
26.4
25.76
25.58
25.37
25.69
25.85
25.9
Profit Margin (%)
15.58
16.57
17.39
23.76
25.42
27.33
27.13
Working Capital
183
304
253
389
546
685
- -
LT Debt
27
22
- -
- -
- -
10
- -
Total Equity
268
404
447
663
901
1,161
- -
Return on Invested Capital (%)
- -
35.85
34.97
36.79
30.53
23.22
- -
Return on Capital (%)
- -
37.57
37.76
38.48
32.56
26.7
- -
Return on Common Equity (%)
- -
40.58
39.08
38.48
32.56
26.82
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
6
- -
LT Borrowings
- -
10
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
5,185
3,600
5,564

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
788
- -
Cash, Cash Equivalents & STI
- -
487
- -
Accounts Receivable, Net
- -
212
- -
Inventories
- -
84
- -
Total Current Liabilities
- -
104
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
6
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
34.88%
28.88%
Free Cash Flow
- -
85.21%
-25.4%
Net Income, GAAP
- -
23.67%
8.61%
Sales/Revenue/Turnover
- -
10.89%
1.02%
Total Cash Common Dividend
- -
- -
0.05%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
252
249
240
261
1,002
2026
243
255
253
261
1,012
2027
284
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.67
1.76
1.77
1.7
6.86
2026
1.7
1.82
1.79
2.16
7.45
2027
2
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.5
2026
- -
- -
- -
- -
0.5
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Suresh Kalra
Full Time Employees
70
Sector
Process industries
Industry
Chemicals: specialty
Address
Block No. 284 Vadodara India 391440
IPO Date
Jun 10, 2024
Website
kronoxlabsciences.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Kronox Lab Sciences Ltd. specializes in the production and global distribution of high-purity fine and inorganic chemicals, along with various phosphates and metallic compounds. The company offers a comprehensive range of bulk reagents, including ACS, LR, AR, and GR grades, designed for diverse applications. Its bulk ingredients cater to sectors such as oral hygiene, pharmacopoeia, food and nutraceuticals, personal care, cosmetics, and veterinary pharmaceuticals. Additionally, Kronox Lab Sciences provides an array of specialty chemicals, featuring items like tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and its derivatives, ultra-high purity substances, custom formulations, and specialty anhydrous compounds. Established in 2008, the company operates from its base in Vadodara, India, and successfully completed its Initial Public Offering in June 2024, listing on the BSE and NSE.